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Abstract
Background & Aims: Symptoms of constipation are extremely common, especially in the elderly. The present study aim to
identify an efficacious treatment strategy for constipation by evaluating the secretion-promoting and laxative effect of a
herbal compound, naringenin, on intestinal epithelial anion secretion and a rat constipation model, respectively.
Methods/Principal Findings: In isolated rat colonic crypts, mucosal addition of naringenin (100 mM) elicited a
concentration-dependent and sustained increase in the short-circuit current (ISC), which could be inhibited in Cl
2 free
solution or by bumetanide and DPC (diphenylamine-2-carboxylic acid), but not by DIDS (4, 49- diisothiocyanatostilbene-2,
29-disulfonic acid). Naringenin could increase intracellular cAMP content and PKA activity, consisted with that MDL-12330A
(N-(Cis-2-phenyl-cyclopentyl) azacyclotridecan-2-imine-hydrochloride) pretreatment reduced the naringenin-induced ISC.I n
addition, significant inhibition of the naringenin-induced ISC by quinidine indicated that basolateral K
+ channels were
involved in maintaining this cAMP-dependent Cl
2 secretion. Naringenin-evoked whole cell current which exhibited a linear
I–V relationship and time-and voltage- independent characteristics was inhibited by DPC, indicating that the cAMP activated
Cl
2 conductance most likely CFTR (cystic fibrosis transmembrane conductance regulator) was involved. In rat constipation
model, administration of naringenin restored the level of fecal output, water content and mucus secretion compared to
loperamide-administrated group.
Conclusions: Taken together, our data suggest that naringenin could stimulate Cl
2 secretion in colonic epithelium via a
signaling pathway involving cAMP and PKA, hence provide an osmotic force for subsequent colonic fluid secretion by which
the laxative effect observed in the rat constipation model. Naringenin appears to be a novel alternative treatment strategy
for constipation.
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Introduction
The prevalence of constipation has been reported to be as high
as 20%, especially in the elderly. Studies have shown that if people
only have a bowel movement every 3–4 days, they are more at risk
for having colon cancer, hemorrhoids, irritable bowel disease
(IBS), and many other illnesses. Most remedies for constipation
focus on modulating the motility of the gastrointestinal (GI) tract,
which has been reported with severe side effects. Take examples,
cisapride, a first generation of promotility agent [1] was withdrawn
because of safety concerns (cardiac arrhythmias) [2]. Tegaserod, a
selective 5HT(4) receptor agonist, the most widely used medicine
in the treatment of chronic constipation has been reported to cause
coronary artery contraction, coronary spasm, and even myocar-
dial infarction [3]. Advances in research on the gastrointestinal
physiology and pathology have paved the way for innovative new
approaches to the treatment of patients with chronic constipation.
Although lubiprostone, which enhances gastrointestinal chloride
secretion [4], has extended the therapeutic options available to
patients with chronic constipation [5], it still remains many
adverse events just like nausea, diarrhea, headache and so on [6].
Little medication for constipation is available for promoting the
secretory activity of the GI tract safely.
It is well known that the absorption and secretion of
electrolytes and fluid in the intestine are achieved via different
ion channels, transporters and pumps that are strategically
located on apical and/or basolateral membranes [7]. In
particular, epithelial Cl
2 channels, including the cystic fibrosis
transmembrane conductance regulator (CFTR), play vital roles in
regulating the secretory activities of electrolytes and fluid across
the GI tract, abnormalities of which may result in diarrhea [8–
10] or constipation [11,12]. Therefore, drugs with stimulating
effects on Cl
2 secretion may to some extent meliorate the
symptom of the latter.
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ingested by humans and animals with their regular foods, have
been reported to play an important dietary role in protection
against chronic diseases such as cancer and cardiovascular
diseases; they also have antioxidant and antiproliferative proper-
ties [13–15]. Interestingly, the effects of certain flavonoids on
anion secretion across the intestinal tract in vitro have been noted
previously [16–18]; however, little is known about their use in the
treatment of constipation as well as their direct influence on the GI
mucosa in vivo, where these compounds come in contact with
immediately after oral intake,
Naringenin was supposed to be a potent stimulator of chloride
secretion in colonic epithelia with significant improvement of
symptoms of constipation. The present study examined the effect
of flavanone naringenin (NAR, aglycone), a main active flavonol
compound extracted from Citrus fruits (oranges and grapefruits)
[19], on anion secretion of colonic epithelium and on a rat model
of spastic constipation presenting with reduced colonic mucus
[20], first indicating its therapeutic potential for treatment of
constipation and other relative diseases.
Results
NAR-induced Isc response
The basal ISC in isolated colonic mucosa were 2161.2 mA/cm
2
(n=20) and basolateral application of NAR (5 mM–1 mM) caused
a sustained (Fig. 1A) and concentration-dependent (Fig. 1B)
increase in ISC with an apparent EC50 of about 111.3 mM. NAR-
induced changes in Isc were calculated as current change for
20 min (mA/cm
2) (Fig. 1).
Ionic basis of the NAR-induced ISC
In order to study the ion species involved in mediating the
NAR-induced ISC, a series of ion substitution experiments were
conducted (Fig. 2), and different Cl
2 channel blockers were
examined (Fig. 3A). The change in ISC was defined as the maximal
rise in ISC following NAR stimulation and it was normalized to
current change per unit area of the epithelial monolayer (mA/cm
2).
DIDS (100 mM, n=4, Fig. 3) added to the mucosal side did not
affect the ISC induced by NAR (100 mM), whereas subsequent
application of the Cl
2 channel blocker DPC completely inhibited
the increase in ISC (n=4). Removal of HCO3
2 from the bathing
solution only slightly suppressed the NAR-evoked ISC by 3.1%
(Fig. 2A), whereas Cl
2 elimination strongly inhibited the ISC
increase by 92.1%, (n=4,P,0.001, Fig.2B); while both extracel-
lular Cl
2 and HCO3
2 were removed, the NAR-induced ISC was
reduced by 98.0%, (n=4, P,0.001) (Fig. 2C). These results
suggest that the NAR-induced ISC response should be mainly
contributed by Ca
2+-independent Cl
2 secretion.
To test whether electrogenic sodium absorption was involved in
the NAR-induced ISC responses, a Na
+ channel (ENaC) inhibitor,
amiloride (100 mM), was used (Fig. 3B). The responses to NAR
were not affected by mucosal addition of amiloride. Further
investigation showed that the NAR-induced ISC was completely
abolished by serosal application of bumetanide (a Na
+ -K
+ -2Cl
2
cotransporter inhibitor, 100 mM) (Fig. 3B). Removal of sodium
from the mucosal K-H solution did not affect the NAR-induced
ISC, however, when sodium free solution was applied to both sides
of the mucosa, the NAR-induced ISC increase was inhibited by
96.7% (Figure 3C), excluding the participation of mucosal sodium
absorption.
Owing to the important role for maintaining the driving force
for chloride secretion [21], involvement of basolateral membrane
K
+ channel was also investigated, serosal application of quinidine
(100 mM) significantly inhibited the NAR-evoked Isc (Figure 3D),
indicating that blocking of basolateral K
+ channels could also
affect Cl
2 secretion.
Involvement of cAMP and PKA activity in mediating the
effect of NAR
As shown in Fig. 1, NAR caused a long-lasting stimulation on
ISC which is more likely to be a cAMP-mediated short circuit
current reaction. In the presence of forskolin (an adenylate cyclase
activator), which was used to exhaust the adenylate cyclase so that
there will be no further elevation in intracellular cAMP upon
subsequent addition of cAMP elevating agents, the NAR induced
ISC increase was almost completely abolished (n=4, P,0.001,
Fig. 4A, B). Coordinately, pretreatment with MDL-12330A (an
inhibitor of adenyl cyclase) for 30 minutes dramatically reduced
the NAR induced ISC compared with control (n=4, P,0.001,
Fig. 4C, D).
ELISAs (enzyme linked immunosorbent assay) data presented in
Figure 5 confirm that the cAMP dependent pathway was involved
in mediating the NAR-induced response. The intracellular cAMP
content under basal condition (0.1% dimethyl sulfoxide (DMSO),
both sides) was 108.80610.60 pmol/mg protein (n=3), while after
incubation with serosal NAR (100 mM), the cAMP level was
181.3468.79 pmol/mg protein (n=3). Effect of phosphodiesterase
inhibitor IBMX (3-isobutyl-1-methylxanthine, 100 mM) was detect-
Figure 1. Effect of NAR on anion transport across rat colonic
mucosa. (A) NAR 100 mM on basolateral (bl) side resulted in an
increase in short circuit current (ISC), (B) NAR (1 mM–1 mM) stimulated a
concentration-dependent short circuit current response (n=5). Differ-
ent concentrations of NAR were added to basolateral side. Each data
point represents a mean6SE.
doi:10.1371/journal.pone.0003348.g001
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cAMP levels, IBMX alone caused an increase in cAMP levels to
159.60619.68 pmol/mg protein (n=3), whereas incubation with
100 mM NAR in the presence of IBMX (100 mM) led a significant
increase in cAMP levels to 214.1865.00 pmol/mg protein.
PKA activity was also measured, as shown in Figure 6, NAR
incubation for 5, 10 and especially 15min could increase the PKA
activity by 14.63%,15.12% and 32.89%, respectively, compared
with which was pretreated with DMSO alone. These results
unequivocally demonstrate that NAR could stimulate an increase
in cytosolic cAMP content maybe through activating the adenyl
cyclase rather than inhibiting the activity of phosphodiesterase,
which in turn activate PKA, hence promote Cl
2 secretion across
rat colonic mucosa.
Characteristic of the NAR-induced whole cell current
In the whole cell patch clamp experiments, addition of 100 mM
NAR resulted in an inward current at holding potential 230 mV.
The NAR-activated whole-cell current profile elicited by a series of
voltages exhibited time- and voltage-independent characteristics
with a linear I–V relationship (Figure 7A–C).The I–V relation-
ships were shown in Figure 6D. The reversal potential of the
NAR-induced currents in symmetrical Cl
_ solutions was close to
the Cl
2 equilibrium, 0 mV. In order to further identify whether
the NAR-activated whole-cell currents were mediated by Cl
2, and
not through any nonselective conductance, Cl
2 concentration in
the bath was changed from 140 mM to 70 mM while a pipette
containing 140 mM NMDG (N-Methyl-D-Glucamine) -Cl was
used. As shown in Figure 6, the reversal potential was shifted to a
value 17.3 mV, close to the new theoretic equilibrium value for
Cl
2 18.7 mV (Figure 7E). The results suggested that currents
activated by extracellular naringenin were mediated by Cl
2.
Chloride channel blocker DPC blocked the NAR-activated Cl
2
current when the membrane potential was held at negative
potentials (Figure 7C). This voltage-dependent blockade by DPC
was in line with the characteristic of CFTR previously reported in
other epithelial cells [22,23].
Effect of NAR on rat constipation model
The body weight did not differ significantly between the
experimental groups during the experiment. Compared with
control group, loperamide markedly reduced the frequency of
fecal output (Figure 8A), number of fecal pellet (Figure 8B), fecal
water content (Figure 8C) and the average thickness of the mucus
layer at the fecal surface (Figure 8D), while all of which were
partially restored by NAR with no diarrhea observed.
Figure 2. Ionic basis of NAR-evoked Isc. Representative ISC recording with arrows indicating NAR (100 mM) added basolaterally,. Values are
mean6SE; ** P,0.001. (A) HCO3
2-free K-HS; (B) Cl-free K-HS; (C) Cl
2/HCO3
2-free K-HS; (D) Comparison of NAR-induced total charges transferred in
normal, HCO3
2-free K-HS, Cl
2 free K-HS and Cl
2/HCO3
2-free K-HS.
doi:10.1371/journal.pone.0003348.g002
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The present study aimed to identify a rational, efficacious, and
ideally cost-effective treatment strategy for constipation. Flavo-
noids are a group of small molecules derived from plant-based
compounds of the common flavone (2-phenyl-g-benzopyrone)
structure. Previous study has found that one of the flavonoids,
apigenin, could activate CFTR owing to its specific structural
components [24]. As CFTR is thought to be the primary pathway
for Cl
2 and fluid transport into the intestinal lumen in cAMP-
mediated secretion, there has been a surge of interest in
discovering small molecular activators of CFTR that could
potentially be used for clinical therapies [25].
The present study has demonstrated for the first time that
naringenin (49, 5, 7-trihydroxyflavone) is able to stimulate cAMP-
dependent Cl
2 secretion across human colonic epithelia and
produce laxative effect on loperamide-induced constipation in rats.
These effects are primarily unveiled by the results that NAR could
activate an immediate and sustained increase in ISC, which is due
largely to an increased Cl
2 secretion rather than electrogenic Na
+
absorption. The supporting evidence includes: (i) removal of Cl
2
from the bathing solution greatly attenuated the NAR-induced ISC,
however, removal of both Cl
2 and HCO3
2 did not further reduce
the ISC increase to NAR; (ii) Neither Na
+ ion replacement in the
bathing solutions, nor the pretreatment of the colonic mucosa by
amiloride (ENaC blocker) had significant effect on the short circuit
current induced by NAR. Furthermore, the observation that
NAR-induced current was sensitive to both Na
+-K
+-2Cl
2
cotransporter inhibitor bumetanide and Cl
2 channels blocker
DPC suggests that the NAR-induced ISC is largely due to mucosal
Cl
2 secretion. Since Cl
2 secretion, coupled with paracellular Na
+
secretion, is primarily the driving force for fluid secretion across
the GI tract, the ability of NAR to promote colonic Cl
2 secretion
indicates its potential use for reduce symptoms of constipation.
It has been clearly established that electrolytes transport
stimulated by elevation of intracellular cAMP were largely
dependent on a Cl
2 channel CFTR across wide range of tight
epithelia, such as in the airways and the GI tract. In the present
study, it is most likely that the long-lasting ISC response to NAR
was mediated through cAMP signaling pathways which then
Figure 3. Effect of different channel blockers and bumetanide on Isc evoked by 100 mM NAR in rat colonic mucosa. (A) Stimulation
with NAR on basolateral side resulted in an increase in ISC, which is not abolished by DIDS (100 mM, apical), but by apical (ap) application of DPC
(1 mM). (B) The NAR induced Isc increases doesn’t change when the tissue was pretreated with amiloride (ENaC blocker, 100 mM), but was abolished
by basolateral application of 100 mM bumetanide. (C) Comparison of NAR (100 mM)-induced ISC obtained in control (normal K-H solution), apical Na
+-
free K-H solution with basal normal K-H solution, Na
+-free K-H solution on both sides. (**P,0.001 vs. control). (D) Qunindine (100 mM, bl) inhibited
NAR (100 mM, bl) stimulated ISC.
doi:10.1371/journal.pone.0003348.g003
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+ channels.
This was substantiated by the inhibitory effect of a K
+ channel
blocker, quinindine (Figure 3D) and MDL12330A (Figure 4C), an
inhibitor of adenylate cyclase, on the NAR-induced ISC. Moreover,
after a maximal stimulation of cAMP dependent secretion by
forskolin, NAR was not able to further increase the ISC (Figure 4A),
suggesting that both naringenin and forskolin may share a
common intracellular second messenger pathway. In addition,
ELISA measurement indeed showed that a significant increase in
colonic cAMP production could be induced by 100 mM NAR.
Pretreatment of colonic mucosa with NAR in the presence of
IBMX could further increase the cAMP content compared with
IBMX alone, demonstrating the possibility that naringenin might
have activated the basolateral adenylyl cyclase rather than
inhibited phosphodiesterase. However, further experiments are
required to investigate which adenylyl cyclase isoforms account for
the effect of naringenin on the generation of these regulatory
signals. PKA, which is downstream of cAMP in the signaling
pathway, was also activated by naringenin. As elucidated in several
studies, CFTR activation is normally regulated by ATP release,
elevation of cytosolic cAMP [26] and protein kinase A (PKA). It is
therefore that the ISC response to NAR was most likely mediated
by intracellular cAMP production generated by adenylate cyclase,
which in turn activates PKA and subsequently the apical cAMP-
dependent chloride channel that was probably CFTR. The
inhibition of the NAR-induced ISC by DPC, further demonstrates
the involvement of CFTR.
To further confirm whether CFTR was involved in the NAR
induced chloride secretion, we also performed whole-cell patch-
clamp experiment on T84 cells, with several lines of evidence
Figure 4. Pretreatment with forskolin reduced NAR–induced ISC on rat colonic mucosa by 95.2% (A and B) [**P,0.001 vs. control].
Pretreatment with MDL-12330A reduced NAR–induced Isc by 98.0% (C and D) [**P,0.001 vs. control]. Each column represents the mean6SE (n=5).
doi:10.1371/journal.pone.0003348.g004
Figure 5. Effect of NAR on intracellular cAMP level of rat
colonic mucosa. Comparison of the cAMP generation induced by
IBMX (100 mM, both sides), NAR (NAR; 100 mM, mucosal), forskolin (Fors;
0.3 mM, mucosal), each column represents the mean6SE [*P,0.05 vs.
control].
doi:10.1371/journal.pone.0003348.g005
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2 current in the T84 cells is
characteristic of CFTR [27–30]. First, the NAR-activated Cl
2
current was time and voltage independent and exhibited a linear I–V
relationship; Second, as with CFTR, the NAR-activated Cl
2 current
wasinhibited byDPCina voltage-dependentmanner(Figure 7Band
C) [22,23]; Additionally, the demonstrated ability of NAR to activate
CFTR in vitro rules out the therapeutic possibility of naringenin for
constipation through stimulating Cl
2 secretion in vivo.
Indeed, in the present study, the results obtained in vitro were
validated in an in vivo loperamide-induced constipation rat model.
The salient features of this model include less daily fecal excretion,
lower water content and thinner average thickness of mucus of
fecal pellets (Figure 8) compared with the control rats. Although
previous studies reported that the anti-diarrheal activity of
loperamide is mainly due to its inhibitory effect on colonic
peristalsis [31] thus loperamide-induced constipation is considered
to be a model of spastic constipation [32], our data also suggest
that loperamide may inhibit intestinal water secretion as seen in
human jejunum [33]. The frequency and number of fecal
excretion, water content and the layer of acid mucin secreted by
epithelium of the NAR-treated loperamide-administered group
was significantly higher than that in the loperamide-administered
group, suggesting that NAR produces a laxative effect and
alleviate the symptoms of loperamide-induced constipation.
Together with the data obtained from rat mucosa and T84 cells,
the observed laxative effect on the constipation model is likely to
be due to the modulation of electrocytes secretion, rather than
intestinal motility, by NAR. Additionally, western blot experi-
ments showed that there was no difference in CFTR expression
between the control (data not shown), loperamide and NAR-
treated loperamide-administered group, implying the direct
modulation of naringenin on the CFTR function rather than
expression. The recovery of water content, number of fecal pellets
as well as frequency of feces excretion provide convincing evidence
for the therapeutic potential value of naringenin in relieving
constipation and indicate that the frequency and symptoms of
constipation may be reduced by dietary intake of fruits, such as
oranges and grapefruits, where rich content of NAR is found.
In closing, we have demonstrated for the first time that a fruit-
contained flavonoid, NAR, has potent effect on Cl
2 secretion in
rat distal colon and activation of Cl
2 conductance in human
colonic T84 cells, which is mediated by intracellular cAMP-
dependent and PKA involved regulatory pathway. The observed
laxative effect in a rat constipation model indicates the possibility
that oral administration of naringenin may provide an effective
and alternative treatment strategy for prevention and alleviateing
symptoms of constipation.
Materials and Methods
Tissue Preparation
Rat colonic mucosa were used for short circuit current, cAMP
and PKA measurements. Male Sprague-Dawley rats of 200–300 g
body weight were killed by CO2 asphyxiation according to the
guiding principles for the care and use of animals approved by the
ethics committee in Sun Yet-sen University. Four pieces of distal
colon dissected from each animal were rinsed with ice-cold
Phosphate Buffer Solution (PBS), and the muscle layers were
separated from the mucosal side by blunt dissection.
ISC measurements
For all ISC measurement, tissue samples were cut into
appropriate size and then mounted between two halves of
modified ussing chambers with an internal area of 0.45 cm
2.
Electrodes for measuring transepthelial potential difference (PD)
and passing current were connected to the chamber. The
transepithlial PD were clamped at 0 mV, then the short circuit
currents were recorded with VCC MC6 voltage-current clamp
amplifier (Physiologic instrument, San Diego, CA) and simulta-
neously displayed via a signal collection and analysis system (BL-
420E, Chengdu Technology & Market Co. Ltd, China). The
change in ISC was defined as the maximal rise in ISC following
agonist stimulation and was normalized to current change per unit
area of the epithelial monolayer (mA/cm
2). Transepithelial
resistance (Rt) was calculated by measuring the current response
to a 1mV pulse. The ISC value was expressed as positive when the
current flow from mucosal to serosal.
Measurement of intracellular cAMP and Protein Kinase A
(PKA) activity
Cytosolic cAMP concentrations were measured by ELISA. After a
30-min period of equilibration in normal KH solution at 37uC, the
isolated mucosal sheet was treated with DMSO, IBMX, NAR, and
NARwithIBMX,respectively.ThecAMPcontentwasassayedusing
a commercially available enzyme immunoassay kit (Assay Designs,
Inc., Ann Arbor, MI). The tissue residue was dissolved in PBS, and
protein content was determined using a protein assay kit (Sigma, St.
Louis, MO) with bovine serum albumin as the standard. The
concentration of cAMP was presented as picomoles per milligram of
protein. For PKA activity measurement, the isolated colonic mucosa
were incubated with DMSO alone or naringenin for 5, 10 and
15 min and assayed by the PepTagH non-radioactive cAMP-
dependent protein kinase assay system (Promega). The phosphory-
lated and non-phosphorylated samples were separated on a 0.8%
agarosegel at 80 V for 30 min. The gel was photographed under UV
light and the densitometric analyses of bands were performed using
N I Hi m a g e( o b t a i n e df r o mt h eN I Hw e bs i t e s :H t t p : / / r s b . i n f o . n i h .
gov/nih-image).
Figure 6. Effect of naringenin on the PKA activity. A, colonic
mucosa was treated with DMSO alone (control) or 100 mM naringenin
for 5, 10 and 15 min. The positive and negative controls provided by
the assay kit are shown in lanes 5 and 6. B, summarized data showing
the relative grey value as compared with control. Each column
represents the mean6S.E. (*p,0.05).
doi:10.1371/journal.pone.0003348.g006
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PLoS ONE | www.plosone.org 6 October 2008 | Volume 3 | Issue 10 | e3348Figure 7. Characteristics of NAR-induced whole cell current in T84 cells. A, B, and C, typical whole cell currents recorded by holding the
membrane potential at 230 mV and pulsing to voltages in a range of 680 mV in 20-mV steps from (A) a control cell; (B) a cell applied with NAR
(100 mM) to the bath solution; (C) a cell pre-exposed to 100 mM NAR applied with 1 mM DPC; (D) corresponding current-voltage relationship
obtained from currents in A, B and C; (E) Whole-cell recordings obtained after NAR stimulation from a cell bathed in 70 mM NMDGCl with
corresponding I–V relationships. Note that reversal potential was shifted from 0 to 17.3 mV, close to the new ECl=18.7 mV.
doi:10.1371/journal.pone.0003348.g007
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For whole cell patch clamp study, human colonic T84 cell line
obtained from ATCC (American Type Culture Collection) were
maintained in Dulbecco’s modified Eagle’s medium/F-12 supple-
mented with 10% (v/v) fetal bovine serum, 100 U/ml penicillin,
and 100 mg/ml streptomycin. Cells were seeded onto glass
coverslips placed in 12-wells culture plates and incubated in a
5% CO2 incubator at 37uC for 2 days before patch clamp
experiments.
Whole-cell Patch clamp recording
To isolate single T84 cells, the cells were first placed in Ca
2+-
free D-PBS solution (which consist of: 137 mM NaCl; 8 mM
Na2HPO4; 1.5 mM KH2PO4; 2.7 mM KCl) containing 1 mM
EGTA (Ethyleneglycotetraacetic acid) for 10–15 min, and then
moved to a 1 ml chamber mounted on the stage with immersing
lens microscopy system. Signals filtered at 10 KHz were recorded
at room temperature by a Multiclamp700A amplifier, Digidata
1322 series interface (AXON Instrument, Foster City, CA) and
Figure 8. Effect of NAR on the loperamide-induced rat constipation model. (A) Frequency of feces excretion, (B) number, (C) water content
(D) Thickness of fecal mucus of control (left bar in each column), loperamide-administered (middle bar in each column, 1.5 mg/kg, twice a day
loperamide), and NAR-treated (150 mg/kg, twice a day) loperamide-administered rats (right bar in each column,) on experiment day. Each column
represents the mean SE [***P,0.001].
doi:10.1371/journal.pone.0003348.g008
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pipettes were pulled on a horizontal puller P-97 (Sutter instrument
Co., Novato, CA) from glass capillary tube with filament and had
resistances of 3–7 MV. In the episodic recording mode, the
voltage was clamped from 2100 mV to +80 mV, step +20 mV;
while in the gap-free recording mode, the cells were held at
270 mV throughout the period of recording.
Animal experiments
8-week-old male Sprague–Dawley rats of approximately 250 g
body weight were purchased from Guangdong medical laboratorial
animals center (Guangzhou China). Rats had free access to a
standard diet and drinking water were housed individually in
stainless–steel wire–mesh cages in a room maintained at 2460.5uC,
with relative humidity 1465%, and with a daily photo–period of
08:00–20:00h light. Twenty-seven rats were randomly divided into
3 groups, 9 rats each into loperamide and sodium chloride–
administered group, NAR and loperamide–administered and
control groups. The administration of loperamide and NAR were
carried out after a 2–day adaptation period. Loperamide (1.5 mg/
kg, Sigma) and NAR (150 mg/kg, sigma) suspended in 0.9%
sodium chloride were orally administrated to rats twice a day at
08:00 and at 20:00 h on experimental days 1–5, while the control
rats were only taken 0.9% sodium chloride in the same manner as
the experimental rats. Body weight,food intake, fecal water content,
fecal excretion frequency and mucus were measured. The excreted
feces of individual rats were collected into a dish and their wet
weights were measured as immediately as possible after the feces
excretion every day during the experimental period. The feces were
thoroughly lyophilized and their dry weights were measured. The
water content of the fecal pellet was calculated as the difference
between the wet and dry weights of the pellet.
Tissue specimens of the distal colon were taken at 10:00 h on
the experimental day 5. Segments of the distal colon that included
one fecal pellet isolated by ligatures were removed and
immediately fixed with 10% formaldehyde. Fixed tissue segments
were embedded in paraffin and serially cut into cross sections of
10 mm thick. The sections were stained with alcian blue at pH 2.5
and counterstained with Koelnechtrot. We observed these
preparations with a light microscope.
Solutions and Chemicals
The normal KH solution contained (in mM) 117 NaCl, 4.7
KCl, 1.2 MgSO4, 1.2 KH2PO4, 25 NaHCO3, 2.56 CaCl2, and
11.1 Glucose. The solution was kept at 37uC gassed with 95% O2
and CO2 to maintain the pH at 7.4. In Na
+ free solution, NaCl
was replaced with 137 mM NMDG-Cl, NaHCO3 was replaced
with 10 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethane sul-
fonic acid). In Cl
2 free Kreb’s solution, NaCl, KCl and CaCl2
were replaced with the representive salts of gluconate, other
compositions and condition were not altered. In HCO3
2 free
solution, HCO3
2 was substituted by 10 mM HEPES, and the
solution was bubbled with 100% O2. In anion-free solution, the
component is the same as Cl
2-free solution, except NaHCO3 was
replaced with 20 mM Na-gluconate and 10 mM HEPES, and in
the solution the gas was 100% O2. In the patch clamp
experiments, the pipettes were filled with a solution containing
(in mM) 135 NMDGCl, 2 MgCl2, 3 MgATP, and10 HEPES, pH
adjusted to 7.2 with Tris. The bath solution contained (in mM)
135 NMDGCl, 4.7 CsCl, 2.5 CaCl2, 1.2 MgCl2, 1.2 NaH2PO4,1 0
Glucose, and 10 HEPES (pH 7.4).
DIDS was obtained from Calbiochem. acetazolamide, amilo-
ride, bumetanide, DPC, naringenin, NMDG, MDL-12330A, and
quinidine were obtained from Sigma. Stock solutions of all the
chemicals were dissolved in DMSO. Final DMSO concentration
never exceeded 0.1% (v/v).
Data analysis
For Isc measurement, positive currents are defined as those that
would be carried by anions moving from the serosal to mucosal
compartments and are shown as upward deflections of the traces.
Changes in ion transport (ISC) are given as peak values. Student’s t-
test (Figure 1–5) or Tukey’s multiple comparison after a two-way
analysis of variance (ANOVA) (experimental group x day)
(Figure 7) were adopted. All the results are expressed as
mean6SE. Difference were considered significant at error
probabilities smaller than 0.05.
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